FDA approves Arnuity Ellipta as prophylactic therapy of asthma in children aged 5 to 11 years May 23, 2018 No Comments
INTEREST study of Traumakine in ARDS does not meet primary efficacy composite endpoint May 8, 2018 No Comments
RSS